Catégorie : News

Signia Therapeutics will be present at JP Morgan Healthcare Conference (Jan 13-15th 2020)

janvier 09, 2020

SIGNIA THERAPEUTICS will be in San Francisco fo ...

Signia Therapeutics, Cynbiose and the VirPath academic laboratory are partnering on an ambitious collaborative R&D project

décembre 09, 2019

Signia Therapeutics, Cynbiose and the VirPath academic laboratory are partnering on an ambitious collaborative R&D project to adv ...

Appointment of a Chief Business officer for Signia Therapeutics

novembre 18, 2019

Appointment of a Chief Business officer for Signia Therapeutics It is with a great pleasure that Signia Therapeutics announces the ar ...

Signia Therapeutics to be present at the Options for the Control of Influenza X Conference

août 20, 2019

Very pleased to announce that Dr. Andrés Pizzorno - Signia Therapeutics’ cofounder and Project Manager - has been invited by the Sc ...

Signia Therapeutics awarded with the label “French Tech Seed”

mars 15, 2019

Signia Therapeutics is very proud to announce it has been awarded with the label “French Tech Seed” by a wide and independent eval ...

Signia Therapeutics to present at the 2nd i4iD – Immunotherapies for infectious Diseases – conference

novembre 21, 2018

Signia Therapeutics announces it has been selected to present its strategy based on clinical gene expression infection signatures to t ...

1 2 3

Contact us

Do not hesitate to contact us!

Location

L’Atrium – 43 boulevard du 11 novembre 1918 69100 Villeurbanne, France

Phone

(+33) 478771037

Email

contact@signiatherapeutics.com

Leave a comment

Signia therapeutics.com - Copyright 2018. All right reserved.